Zynerba Pharmaceuticals, Inc. logo

Zynerba Pharmaceuticals, Inc. Share Price (NASDAQ: ZYNE)

▲

-1.3

(-100%)

Last updated on

Bell Icon

The stock has been delisted from the stock exchange on 10 Oct 2023

Check the interactive Zynerba Pharmaceuticals, Inc. Stock chart to analyse performance

Zynerba Pharmaceuticals, Inc. Key Stats

Check Zynerba Pharmaceuticals, Inc. key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$1.3
Open
$1.26
Market Capitalization
$68.5M
Today's Volume
$862.0K
Revenue TTM
$86.0K
EBITDA
$-38.6M
Earnings Per Share (EPS)
$-0.8
Dividend Yield
0.0%
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-87.13%

Global Institutional Holdings in Zynerba Pharmaceuticals, Inc.

  • Name

    Holdings %

  • Vanguard Group Inc

    4.04%

  • BlackRock Inc

    1.37%

  • ETF Managers Group, LLC

    1.34%

  • Renaissance Technologies Corp

    1.28%

  • Geode Capital Management, LLC

    0.72%

  • Penserra Capital Management, LLC

    0.41%

Analyst Recommendation on Zynerba Pharmaceuticals, Inc. Stock

Rating
Trend

Buy

    77%Buy

    22%Hold

    0%Sell

Based on 9 Wall street analysts offering stock ratings for Zynerba Pharmaceuticals, Inc.(by analysts ranked 0 to 5 stars)

About Zynerba Pharmaceuticals, Inc.

Zynerba Pharmaceuticals, Inc. operates as a clinical stage specialty pharmaceutical company. The company focuses on developing pharmaceutically produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders. It is developing Zygel, a pharmaceutically produced cannabidiol formulated as a permeation-enhanced gel for transdermal delivery. The company was formerly known as AllTranz, Inc. and changed its name to Zynerba Pharmaceuticals, Inc. in August 2014. Zynerba Pharmaceuticals, Inc. was incorporated in 2007 and is headquartered in Devon, Pennsylvania.
Organization
Zynerba Pharmaceuticals, Inc.
Employees
25
CEO
Mr. Armando Anido MBA
Industry
Health Technology

Important FAQs about investing in ZYNE Stock from India :

What is Zynerba Pharmaceuticals, Inc. share price today?

Zynerba Pharmaceuticals, Inc. share price today is as on at the close of the market. Zynerba Pharmaceuticals, Inc. share today touched a day high of {{1_rba_end}} and a low of {{1_rba_st}}.

What is the 52 week high and 52 week low for Zynerba Pharmaceuticals, Inc. share?

Zynerba Pharmaceuticals, Inc. share touched a 52 week high of {{rba_end}} and a 52 week low of {{rba_st}}. Zynerba Pharmaceuticals, Inc. stock price today i.e. is closed at , lower by 100% versus the 52 week high.

How to invest in Zynerba Pharmaceuticals, Inc. Stock (ZYNE) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Zynerba Pharmaceuticals, Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Zynerba Pharmaceuticals, Inc. Shares .

What is the minimum amount required to buy Zynerba Pharmaceuticals, Inc. Stock (ZYNE) from India?

Indian investors can start investing in Zynerba Pharmaceuticals, Inc. (ZYNE) shares with as little as ₹88.019 or $1 (as of October 22, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹880.19 in Zynerba Pharmaceuticals, Inc. stock (as per the Rupee-Dollar exchange rate as on October 22, 2025). Learn more about fractional shares .

What are the returns that Zynerba Pharmaceuticals, Inc. has given to Indian investors in the last 5 years?

Zynerba Pharmaceuticals, Inc. stock has given 0.0% share price returns and 19.59% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?